“Huge-Seller” Re-Pricing Eroding Predictability of Japanese System: FPMAJ’s Kamoya

Yoshiaki Kamoya, chairman, FPMAJ drug pricing study group A new special re-pricing rule for fast-growing blockbusters , dubbed “huge-seller” re-pricing, will undermine predictability in the Japanese drug pricing system, which has been given high marks by drug makers at home...read more